Literature DB >> 2668081

The effect of acute and chronic insulin administration on insulin-like growth factor-I expression in the pituitary-intact and hypophysectomised rat.

E A Salamon1, J Luo, L J Murphy.   

Abstract

Although growth hormone is known to be the main regulator of insulin-like growth factor-I, insulin has also been shown to play a role in regulating serum insulin-like growth factor I levels in diabetic animals. While this effect is thought to be due to correction of metabolic perturbations, some studies have suggest that insulin may have a direct effect on growth and/or insulin-like growth factor-I levels. We have examined the effects of acute and chronic insulin administration to non-diabetic, pituitary-intact and hypophysectomised rats. Rats were injected intraperitoneally with insulin as an acute bolus (10 U) or a chronic subcutanious infusion (low dose; 2.4 U/day, high dose; 12 U/day) over 5 days. Insulin-like growth factor-I mRNA was quantitated by Northern and slot blots of RNA from various tissues. A small (less than 2-fold) but significant increase (p less than 0.05) was seen in hepatic insulin-like growth factor-I mRNA abundance in pituitary-intact rats following acute insulin injection and chronic low dose insulin infusion. An increase in insulin-like growth factor-I mRNA levels was also seen in other tissues including diaphragm, lung, kidney and heart. A significant increase (p less than 0.05) in serum insulin-like growth factor-I levels was also observed 6 h after insulin injection. In contrast, in pituitary-intact rats which received high dose insulin infusion and were hypoglycaemic at the time of death, tissue levels of insulin-like growth factor-I mRNA were reduced compared to saline-treated control groups.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2668081     DOI: 10.1007/bf00277257

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  32 in total

Review 1.  Current concepts of somatomedin and other biologically related growth factors.

Authors:  R H Chochinov; W H Daughaday
Journal:  Diabetes       Date:  1976-10       Impact factor: 9.461

Review 2.  Nonsuppressible insulin-like activity (NSILA) from human serum: recent accomplishments and their physiologic implications.

Authors:  J Zapf; E Rinderknecht; R E Humbel; E R Froesch
Journal:  Metabolism       Date:  1978-12       Impact factor: 8.694

3.  Variation among human 28S ribosomal RNA genes.

Authors:  I L Gonzalez; J L Gorski; T J Campen; D J Dorney; J M Erickson; J E Sylvester; R D Schmickel
Journal:  Proc Natl Acad Sci U S A       Date:  1985-11       Impact factor: 11.205

4.  Role of the liver in regulating somatomedin activity: effects of streptozotocin diabetes and starvation on the synthesis and release of insulin-like growth factor and its carrier protein by the isolated perfused rat liver.

Authors:  L L Miller; D S Schalch; B Draznin
Journal:  Endocrinology       Date:  1981-04       Impact factor: 4.736

5.  The effects of insulin and growth hormone on the release of somatomedin by the isolated rat liver.

Authors:  W H Daughaday; L S Phillips; M C Mueller
Journal:  Endocrinology       Date:  1976-05       Impact factor: 4.736

6.  Purification of biologically active globin messenger RNA by chromatography on oligothymidylic acid-cellulose.

Authors:  H Aviv; P Leder
Journal:  Proc Natl Acad Sci U S A       Date:  1972-06       Impact factor: 11.205

7.  Effect of insulin and nutrition on serum levels of somatomedin A in the rat.

Authors:  K Takano; N Hizuka; K Shizume; Y Hasumi; M Kogawa; T Tsushima
Journal:  Endocrinology       Date:  1980-11       Impact factor: 4.736

8.  Insulin stimulation of somatomedin A production in monolayer cultures of rat hepatocytes.

Authors:  M Kogawa; K Takano; K Asakawa; N Hizuka; T Tsushima; K Shizume
Journal:  Acta Endocrinol (Copenh)       Date:  1983-07

9.  Low plasma somatomedin-C in streptozotocin-induced diabetes mellitus. Correlation with changes in somatogenic and lactogenic liver binding sites.

Authors:  M Maes; J M Ketelslegers; L E Underwood
Journal:  Diabetes       Date:  1983-11       Impact factor: 9.461

10.  Direct demonstration of separate receptors for growth and metabolic activities of insulin and multiplication-stimulating activity (an insulinlike growth factor) using antibodies to the insulin receptor.

Authors:  G L King; C R Kahn; M M Rechler; S P Nissley
Journal:  J Clin Invest       Date:  1980-07       Impact factor: 14.808

View more
  5 in total

Review 1.  Diabetic nephropathy. Its relationship to hypertension and means of pharmacological intervention.

Authors:  T Baba; S Neugebauer; T Watanabe
Journal:  Drugs       Date:  1997-08       Impact factor: 9.546

2.  Distribution of IGF-I mRNA and IGF-I binding sites in the rat kidney.

Authors:  G L Matejka; P S Eriksson; B Carlsson; E Jennische
Journal:  Histochemistry       Date:  1992

3.  Differential expression of insulin-like growth factor-I and insulin-like growth factor binding protein-1 in the diabetic rat.

Authors:  J M Luo; L J Murphy
Journal:  Mol Cell Biochem       Date:  1991-04-24       Impact factor: 3.396

4.  Obesity-related promotion of aberrant crypt foci in DMH-treated obese Zucker rats correlates with dyslipidemia rather than hyperinsulinemia.

Authors:  Tatiana C L Koch; Karlis Briviba; Bernhard Watzl; Achim Bub; Stephan W Barth
Journal:  Eur J Nutr       Date:  2008-05-15       Impact factor: 5.614

Review 5.  The link between insulin resistance and hypertension. Effects of antihypertensive and antihyperlipidaemic drugs on insulin sensitivity.

Authors:  T Baba; S Neugebauer
Journal:  Drugs       Date:  1994-03       Impact factor: 9.546

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.